FDA Classifies Spinal Imaging System for Neuraxial Procedures as Class II

The U.S. FDA has issued a final order classifying spinal imaging systems used in neuraxial procedures into Class II, effective October 30, 2026. This regulatory decision establishes special controls, alongside general controls, to ensure the safety and effectiveness of these medical devices. The classification provides clear guidelines for manufacturers and healthcare providers.